产品中心 药物靶点和Fc受体 药物靶点

所有图片(1/1)

LILRA5/CD85f/ILT11 Fc Chimera Protein, Human

价格 4,000.00 供应商现货 : 3-5个工作日
货号 UA010023
规格
数量
收藏 分享

关联产品推荐

产品介绍 评论(0)

产品规格
  • 物种

    Human
  • Accession

    A6NI73-1
  • 表达序列

    Gly42-Arg268, with C-terminal Human IgG Fc
  • 表达宿主

    HEK293
  • 分子量

    60-65 kDa(Reducing)
  • 纯度

    >95%, by SDS-PAGE under reducing conditions
  • 内毒素含量

    <0.1EU/μg
  • 标记

    Unconjugated
  • 标签

    Human Fc Tag
  • 性状

    Lyophilized Powder
  • 缓冲体系

    PBS, pH7.4
  • 溶解方法

    Reconstitute at less than 1 mg/mL according to the size in ultrapure water after rapid centrifugation .
  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.
背景介绍
  • Leukocyte immunoglobulin-like receptor A5 (LILRA5) belongs to a family of receptors known to regulate leukocyte activation, which encoded within the leukocyte receptor cluster (LRC) on human chromosome 19. LIRs are transmembrane proteins containing either two or four extracellular immunoglobulin domains, and most family members are expressed predominantly on myeloid cell lineages. Cross-linking of LILRA5 on monocytes induced production of pro-inflammatory cytokines, suggesting that LILRA5 plays a role in inflammation. Furthermore, LILRA5 induced selective production of pro-inflammatory cytokines as well as IL-10. LILRA5 mRNA and protein expression was tightly regulated by TNF-α, IL-10 and IFN-γ. Increased expression of LILRA5 in rheumatoid tissue, together with its ability to induce key cytokines involved in RA, suggests that this novel receptor may contribute to disease pathogenesis.

  • 电泳

    • LILRA5/CD85f/ILT11 Fc Chimera, Human ,1μg on SDS-PAGE under reducing and Non-reducing condition. The purity is greater than 95%.

评论(0)